Page last updated: 2024-12-07

3,3,3-trifluoroalanine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

3,3,3-trifluoroalanine: RN refers to (DL)-isomer; inhibits pyridoxal-5'-phosphate dependent cystathionine beta-lyase [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID2734920
CHEMBL ID4645218
SCHEMBL ID202704
MeSH IDM0065972

Synonyms (30)

Synonym
3,3,3-trifluoroalanine
trifluoroalanine
3,3,3-trifluoro-dl-alanine, 98%
17463-43-3
2-amino-3,3,3-trifluoropropanoic acid ,
AKOS005257592
3,3,3-trifluoro-dl-alanine
dl-3,3,3-trifluoro-2-alanine
FT-0625397
c3h4f3no2
2-amino-3,3,3-trifluoropropionic acid
SCHEMBL202704
mfcd00004263
STL554943
AKOS032963160
FS-6311
BBL101147
(r)-3,3,3-trifluoro-2-aminopropanoic acid
AMY36517
N12407
CHEMBL4645218
CS-W018267
mfcd19207333
SY275074
SY307763
HY-W017551
SY344717
3,3,3,-trifluoro-d-alanine
mfcd07779864
EN300-96746
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1654587Substrate activity at Escherichia coli B alanine racemase assessed as Km2020Journal of medicinal chemistry, 06-25, Volume: 63, Issue:12
Metabolic and Pharmaceutical Aspects of Fluorinated Compounds.
AID1654588Substrate activity at Escherichia coli B alanine racemase assessed as partition ratio by measuring ratio of turnover rate to inactivation rate2020Journal of medicinal chemistry, 06-25, Volume: 63, Issue:12
Metabolic and Pharmaceutical Aspects of Fluorinated Compounds.
AID1654586Substrate activity at Escherichia coli B alanine racemase assessed as Vmax2020Journal of medicinal chemistry, 06-25, Volume: 63, Issue:12
Metabolic and Pharmaceutical Aspects of Fluorinated Compounds.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (33.33)18.7374
1990's2 (22.22)18.2507
2000's2 (22.22)29.6817
2010's1 (11.11)24.3611
2020's1 (11.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]